ArticleJournal of neurochemistry2026
Multifaceted Immune Effects of the Scavenger Receptor CD36 on Long-Term Outcomes After Neonatal Arterial Focal Stroke.
Article in Journal of neurochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The scavenger receptor CD36 is a versatile receptor that regulates various inflammatory processes by interacting with different ligands in concert with other receptors in a context- and cell-type-specific manner. While CD36 is injurious in acute adult stroke, it is beneficial in acute perinatal stroke. This differing acute response may be influenced by the maturation-dependent availability of CD36 receptor partners in the brain, such as Toll-like receptors (TLRs), the developmental state of the blood-brain barrier, and leukocyte subtypes during injury. Here, we further explore CD36-TLR2 interactions in neonatal brain injury by examining whether CD36 similarly affects gene expression and leukocyte trafficking via the blood-CSF barrier/choroid plexus after transient middle cerebral artery occlusion and direct TLR2 stimulation in wild type and CD36 knockout mice. We then examine the consequences of CD36 deficiency for long-term injury outcomes after neonatal stroke. We demonstrate that CD36 deficiency affects long-term behavior performance under physiological conditions and a shift in the role of CD36 from beneficial during acute injury to detrimental in the chronic phase following neonatal stroke. We further show that CD36 contributes to sustained immune responses, as indicated by long-term alterations in microglial phenotypes, and influences long-term functional outcomes. Collectively, these findings underscore the complex time-dependent roles of CD36 and provide insight into the mechanisms by which it modulates ischemic injury in neonatal mice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.